APOC3 and hyperlipidemia: Of note is the human leukocyte antigen subtype B*57:01; a strong predictor of abacavir hypersensitivity reactions [6,7], as well as variants of the Apolipoprotein C3 (APOC3) promoter region such as C-482T and T-455C associated with development of hyperlipidemia [8,9].